03 noiembrie 2023
Ce este infertilitatea? 10 Pași în Tratamentul cu Fertilizare in Vitro
Din 2020, continuă să lucreze ca Director al Centrului de Fertilizare In Vitro al Spitalului Anadolu.
Certificări:
1. Kutlu T, Özkaya E, Şanverdi I, Çakar E, Ayvacı H, Devranoğlu B, Karateke A. Modificări acute ale trasării frecvenței cardiace fetale secundare fumatului de țigară în sarcinile din trimestrul al treilea. The Journal of Maternal Fetal Neonatal Medicine, 2017 30(12), 1407-1409.
2. Kutlu T, Özkaya E, Ayvacı H, Devranoğlu B, Şanverdi İ, Şahin Y, Şenol T, Karateke A. Zona sub curbă a măsurătorilor temporale ale estradiolului pentru prezicerea efectului dăunător al expunerii la estrogen asupra implantării. International Journal of Gynecology and Obstetrics, 2016, 135(2), 168-171.
3. Kutlu T, Tuğrul S, Aydın A, Oral Ö. Meningita tuberculoasă în sarcină prezentată ca hiperemeză gravidică. J Matern Fetal Neonatal Med. 2007 Apr;20(4):357-9.
4. Kutlu T, Tuğrul S, Aran T, Uslu H, Eren S, Oral Ö. Administrarea combinată a misoprostolului în cazurile de avort missed în primul și al doilea trimestru. Clin Exp Obstet Gynecol. 2006;33(4):226-8.
5. Kutlu T, Ficicoglu C, Başaran T, Başaran E, Topaloğlu T. Modificări ale densității mamografice a sânului după 1 an de utilizare a tibolonei. Maturitas. 2004 Jun 15;48(2):133-6.
6. Ozkaya E, Kutlu T, Abide Yayla C, Kayatas Eser S, Sanverdi I, Devranoglu B. Zona sub curbă a măsurătorilor temporale de estrogen și progesteron în timpul tehnologiilor de reproducere asistată: Care hormon este principalul determinant al rezultatului ciclului? J Obstet Gynaecol Res. 2018; 44(2):263-269.
7. Sanverdi I, Kutlu T, Bilgic BE, Incebiyik A. O comparație a rezultatelor tratamentului diferitelor protocoale de tratament la pacienții cu răspuns ovarian slab. Gynecol Endocrinol. 2018; 34(6):524-527.
8. Kara M, Kutlu T, Sofuoglu K, Devranoglu B, Cetinkaya T. Asocierea între nivelul seric de estradiol în ziua administrării hCG și rezultatul IVF-ICSI. Iran J Reprod Med. 2012, 10(1), 53-58.
9. Tuğrul S, Kutlu T, Pekin O, Bağlam E, Kıyak H, Oral Ö. Efectele clinice, endocrine și metabolice ale acarbosei, inhibitorul alfa-glucosidazei, la pacienții cu PCOS supraponderali și non-supravponderali. Fertil Steril. 2008 Oct;90(4):1144-8.
10. Ficicioglu C, Kutlu T, Baglam E, Bakacak Z. Hormonul antimullerian în foliculul timpuriu ca indicator al rezervelor ovariene. Fertil Steril. 2006 Mar;85(3):592-6.
11. Oral O, Kutlu T, Aksoy E, Ficicioglu C, Uslu H, Tugrul S. Efectele stresului oxidativ asupra rezultatelor tehnicilor de reproducere asistată. J Assist Reprod Genet. 2006 Feb;23(2):81-5.
12. Ficicioglu C, Kutlu T, Taşdemir S, Altuntaş L. Efectele diferitelor analoge ale hormonului de eliberare a gonadotropinelor în ciclurile IVF. MEFSJ. 2005; 10(3): 212-8.
13. Ficicioglu C, Kutlu T, Demirbasoglu S, Mulayim B. Rolul inhibinei B ca determinant bazal al rezervelor ovariene. Gynecol Endocrinol. 2003 Aug;17(4):287-93.
14. Ficicioglu C, Kutlu T. Rolul androgenelor în etiologia și patologia preeclampsiei. J Obstet Gynaecol. 2003 Mar;23(2):134-7.
15. Çakar E, Yavuz MM, Kutlu T, Ayvacı Taşan H, Cogendez E, Beydilli Nacak G, Özkaya E, Kayataş Eser S. IVf versus sarcini spontane unice: rezultate fetale și materne într-un spital terțiar. International Journal of Medical Science and Clinical Invention 2018, 5(03): 3583-3587.
16. Kara M, Sofuoglu K, Kutlu T, Devranoglu B, Çetinkaya T. Compararea eficienței și cost-eficienței hormonului folicular purificat urinar (HP-uFSH) și hormonului folicular recombinant (rFSH) la răspunsuri slabe. Journal of the Dow University of Health Sciences Karachi 2011, Vol. 5 (2): 43-46.
17. Yiginer O, Dogan M, Gun I, Kutlu T, Degirmencioglu G, Guliyev İ, Tokatli A, Kilicaslan F. Efectele nivelurilor supraphysiologice de estrogen asupra parametrilor de repolarizare ventriculară. Kardiol Pol. 2018 Feb 5. doi: 10.5603/KP.a2018.0037.
18. Şahin Y, Özkaya E, Kayataş Eser S, Kutlu T, Şanverdi İ, Tunalı G, Karateke A. Concentrațiile serice de substanță P pentru a prezice indicele de maturare a ovocitelor și sarcina clinică. Gynecological Endocrinology, 2017, 33(3), 203-207.
19. Aydın GA, Yavuz A, Terzi H, Kutlu T. Evaluarea relației dintre nivelurile serice bazale de hormon antimullerian și calitatea ovocitelor și rezultatele sarcinii la pacienții care urmează ICSI. Iran J Reprod Med 2015, 13(4), 231-236.
20. Tugrul S, Oral O, Guclu M, Kutlu T, Uslu H, Pekin O. Semnificația ecografiei Doppler în diagnosticarea sindromului ovarului polichistic. Clin Exp Obstet Gynecol. 2006;33(3):154-8.
21. Tugrul S, Yildirim G, Pekin O, Uslu H, Kutlu T, Eren S. Compararea a două forme de terapie hormonală de substituție combinată continuă cu privire la efectele metabolice. Arch Gynecol Obstet. 2007 May;275(5):335-9.
22. Çakar E, Ayvaci Tasan H, Kumru P, Cogendez E, Tarhan N, Kutlu T, Özkaya E, Kayatas Eser S. Utilizarea combinată a estradiolului și progesteronului pentru a susține faza luteală în ciclurile de injecție intracytoplasmatică a spermatozoizilor (ICSI) ale femeilor normorespondente: un studiu de caz-control. Journal of Obstetrics and Gynaecology. 2019, 1-6.
23. Kurek Eken M, Sahin Ersoy G, Yayla Abide Ç, Sanverdi İ, Devranoglu B, Kutlu T, Çevik Ö. Asocierea între nivelurile circulante de neuregulină 4 și profilul metabolic, aterogenic și AMH al sindromului ovarului polichistic. Journal of Obstetrics and Gynaecology. 2019, 1-6.
24. Abide Yayla C, Ozkaya E, Beydilli Nacak G, Sanverdi I, Devranoglu B, Bostanci Ergen E, Kilicci C, Kutlu T. Expunerea mare la estrogen nu poate fi dăunătoare pentru receptivitatea endometrială la femeile cu PCOS. Gynecol Endocrinol. 2018; 34(3):229-233.
25. Abide Yayla Ç, Özkaya E, Kayataş Eser S, Şanverdi İ, Devranoğlu B, Kutlu T. Association of basal serum androgen levels with ovarian response and ICSI cycle outcome. Ir J Med Sci. 2018; 187(2):409-415.
26. Ovayolu A, Özdamar Ö, Gün İ, Arslanbuğa CY, Kutlu T, Tunalı G, Uluhan R. The assessment of follicular fluid presepsin levels in poor ovarian responder women and its relationship with the reproductive outcomes. Int J Clin Exp Med 2015;8(6):9961-9966.
27. Bilgic BE. Yayla Abide C, Ozkaya E, Kutlu T, Ayla Ş, Şanverdi İ, Tunalı G, Yucel E, Kanbur S. Role of Oocyte Morphological Abnormality Rates on the Embryo Development and Implantation. Gynecol Obstet Reprod Med 2018; DOI:10.21613/GORM.2018.755
28. Bozdağ H, Akdeniz E, Devranoğlu B, Haksever M, Bilgiç BE, Kutlu T. Cytoplasmic abnormalities of mature oocytes have a significant effect on fertilization in Bologna poor responders. Turkish Journal of Medical Sciences. 2018; 48(4), 750-758.
29. Yayla Abide Ç, Özkaya E, Kayataş Eser S, Devranoğlu B, Bilgiç BE, Kutlu T. Serum Albumin Level Adjusted Progesterone Level on the Trigger Day is Not a Significant Predictor of Clinical Pregnancy. Gynecol Obstet Reprod Med 2018; DOI:10.21613/GORM.2017.771
30. Devranoğlu B, Yayla Abide Ç, Özkaya E, Şenol T, Kutlu T, Kayataş Eser S. Coagulation Tests at Trigger Day in Patients with Factor V Leiden Mutation to Predict Implantation Failure. Gynecol Obstet Reprod Med 2018; DOI:10.21613/GORM.2017.754
31. E Özkaya, ÇA Yayla, SK Eser, B Devranoğlu, I Şanverdi, T Kutlu (2018). Short Term Alterations of Hormone Profile Following Oocyte Pick-Up in Women with Polycystic Ovarian Syndrome to Assess the Effect of Multiple Needle Entries Into The Ovarian Cortex and Stroma. Gynecology Obstetrics & Reproductive Medicine 24 (1), 17-21
32. Çakar E, Yavuz MM, Kutlu T, Ayvacı Taşan H, Cogendez E, Beydilli Nacak G, Özkaya E, Eser SK (2018). IVF versus spontaneous singleton pregnancies fetal and maternal outcomes in a tertiary care hospital. International Journal of Medical Science and Clinical Invention; 5(3), 3583-3587.
33. BE Bilgiç, E Özkaya, T Kutlu, SK Eser, İ Sanverdi, SB Türkmen (2017). Comparison of Cycle Characteristics of Poor Responders Who Could and Could Not Collect Oocytes Following Transvaginal Follicle Aspiration. Journal of Gynecology, Obstetrics and Neonatology 14 (4).
34. Kutlu T, Özkaya E, Kumru P, Ayvacı H, Devranoğlu B, Şanverdi İ, Şahin Y, Sağlam B, Karateke A (2017). Clinical analyses of successful and previously failed intracytoplasmic sperm injection cycle parameters in patients with poor ovarian reserve. Turkish Journal of Obstetrics and Gynecology, 2017 Mar;14(1):58-63.
35. Özkaya E, Şahin Y, Kayataş Eser S, Albayrak B, Bulduk O, Sanverdi İ, Kutlu T (2017). Does the Modification of Starting Gonadotropin Dose During ICSI Cycle Have Any Significant Impact on Cycle Outcome? Gynecol Obstet Reprod Med; 23(3):138-142
36. Kutlu H T, Özkaya E, Sanverdi I, Devranoğlu B, Ipekçi C, Konukçu B, Yavuz S, Karateke A (2016). Relationship Between The Estradiol-Progesterone Alterations After Ovulation Trigger And Treatment Success In IUI Cycles. Turk J Obstet Gynecol; 13:56-61.
37. Şanverdi İ, Özkaya E, Kutlu T, Şenol T, Akalın M, Akalın E S, Şahin Y, Karateke A (2016). Non-invasive prediction of the implantation window in controlled hyperstimulation cycles: Can the time from the menstrual day at embryo transfer to expected menstrual cycle give a clue? Turkish Journal of Obstetrics and Gynecology, 13, 116-122.
38. Özüm G, Özdamar Ö, Gün I, Sofuoğlu K, Kutlu H T, Tunalı G (2016). The diagnostic value of hysterosalpingography and transvaginal ultrasonography in primary and secondary infertile patients undergoing hysteroscopy. Zeynep Kamil Medical Bulletin, 47(1), 1-5. Doi: 10.16948/zktb.08928
39. Selçuk S, Küçükbaş M, Yenidede I, Kayataş Eser S, Eser A, Çam Ç, Kutlu H T (2016). The outcomes of controlled ovarian hyperstimulation/intrauterine insemination in patients with unilateral tubal occlusion on hysterosalpingograph. Turkish Journal of Obstetrics and Gynecology, 13(1), 7-10.
40. Selçuk S, Özkaya E, Eser A, Kuyucu M, Kutlu H T, Devranoğlu B, Sofuoğlu K, Dayıcıoğlu V E (2016). Characteristics and outcomes of in vitro fertilization in different phenotypes of polycystic ovary syndrome. Turkish Journal of Obstetrics and Gynecology, 13(1), 1-6.
41. Temizkan O, Çöğendez E, Sanverdi I, Temizkan S, Kutlu H T, Ayhan I, Arıcı B, Aşıcıoğlu O (2015). The effects of estradiol and prolactin levels measured on the day of human chorionic gonadotropin administration on embryo quality and pregnancy outcomes in ICSI/ET cycles with down-regulation performed with GnRH agonist or antagonist. The Medical Bulletin of Sisli Hospital, 49(3), 174-180., Doi: 10.5350/SEMB.20150302090129
42. Ayla Ş, Tunalı G, Körkoca N, Beyhan Sağlam, Ural M, Sofuoğlu K, Uslu B, Kutlu T, Devranoğlu B, Büyükbayrak EE, Şahin S. Pregnancy Rates Following Single and Conditional Double Embryo Transfer (Regulation). Zeynep Kamil Medical Bulletin, 45 (4), 156-159, 2014.
43. Baykal B, Çelik C, Bastu E, Kutlu T, Batu P, Abalı R, Eren S. Effect of Antral Follicle Count on in Vitro Fertilization Outcome. J Clin Anal Med, 5(4): 324-327, 2014.
44. Şahin S, Selçuk S, Devranoğlu B, Kutlu T, Kuyucu M, Eroğlu M. Comparison of long GnRH agonist versus GnRH antagonist protocol in poor responders. J Turk Soc Obstet Gynecol, 11, 203-206, 2014.
45. Kara M, Kutlu T, Sofuoğlu K. Comparison of the Recombinant Versus Highly-Purified, Urinary Follicle-Stimulating Hormone (r-FSH vs. HP-uFSH) in the Polycystic Ovary Syndrome Patients who had Antagonist Cycle with In Vitro Fertilization-Embryo Transfer. Turkiye Klinikleri J Med Sci, 31(4):775-9, 2011.
46. Gürleyiğ E, Sanverdi I, Kutlu H T, Muyır R, Eren S (2007). Laparoscopic Management of Benign Adnexal Masses. Haydarpasa Numune Training and Research Hospital Medical Journal, 47(4), 469-473.
47. Kutlu H T, Aran T, Oral Ö, Gürleyiğ E, Altınkaş K, Önal G (2007). Molar Pregnancy in the Perimenopausal Period. Haydarpasa Numune Training and Research Hospital Medical Journal, 47(1).
48. Aköz I, Ayas S, Kutlu H T, Pekin O, Eren S (2006). Tubal Uterine Leiomyoma. Zeynep Kamil Medical Bulletin, 37(4), 95-96.
49. Kutlu H T, Tuğrul A S, Çeçen F, Eren S (2006). Use of Misoprostol Prior to Endometrial Sampling. Journal of Obstetrics and Gynecology, 4(4), 909-913.
50. Gürleyiğ E, Kutlu H T, Altınkaş K, Önal G, Oral Ö (2006). Our General Hospital Experience in the Management of Ectopic Pregnancy: Factors Influencing Surgical Decision Making. Journal of Obstetrics and Gynecology, 5(1), 1006-1009.
51. Kutlu T, Bağlam E, Genç Z, Eren S. The Role of Risk Score, Cervical Length, and Maternal Salivary Estriol Levels in Predicting the Threat of Premature Birth. Zeynep Kamil Medical Bulletin Gynecology-Obstetrics-Pediatrics Clinics, 36(2), 51-55, 2005.
52. Kutlu T, Bağlam E, Eren S. Twin Pregnancy Complicated by Interlocking: A Case Report. Gynecology, Obstetrics & Reproductive Medicine, GORM, 12(1), 47-49, 2006.
53. Usta SS, Kutlu T, Eren S. Do Tibolone and Combined Hormone Replacement Therapy Have a Beneficial Effect on Plasma Lipid Levels in Hyper and Normocholesterolemic Postmenopausal Women? Gynecology, Obstetrics & Reproductive Medicine (GORM), 10(3), 186-190, 2004.
54. Fıçıcıoğlu C, Kutlu T, Başaran T, Yaltı S, Gürbüz B, Taşdemir S. Comparison of Recombinant FSH α and β with Purified Urinary FSH for Controlled Ovarian Hyperstimulation in Assisted Reproductive Techniques. Clinical Sciences & Doctor Journal, 10(5), 579-584, 2004.
55. Aköz İ, Kılıçcı Ç, Kutlu T, Pekin O, Eren S. Adnexal Masses Detected Incidentally During Cesarean Section. Zeynep Kamil Medical Bulletin Gynecology-Obstetrics-Pediatrics Clinics, 35(2), 61-65, 2004.
56. Kutlu T, Bozdağ H, Aköz İ, Pekin O, Usta S, Eren S. The Role of a Single Dose of Indomethacin Suppository in Reducing Opioid Requirements After Cesarean Section. Zeynep Kamil Medical Bulletin Gynecology-Obstetrics-Pediatrics Clinics, 34(3), 1-4, 2003.
57. Bozdağ H, Ertekin K, Kutlu T, Öztürk G, Eren S. Ferritin as an Acute Phase Reactant and Its Use in the Threat of Premature Birth. Zeynep Kamil Medical Bulletin Gynecology-Obstetrics-Pediatrics Clinics, 34(1), 13-18, 2003.
58. Kutlu T, Başaran T, Fıçıcıoğlu C. Prognostic Value of E2 Levels on the Day of Exogenous HCG Administration in Assisted Reproductive Techniques. Zeynep Kamil Medical Bulletin Gynecology-Obstetrics-Pediatrics Clinics, 33(2), 1-4, 2002.
59. Tuğrul S, Köse G, Kutlu T, Demirören T. Maternal Serum Albumin and Prealbumin Levels in Intrauterine Growth Restriction. Journal of Gynecology and Obstetrics, 13(2): 107-111, 1999.
60. Kara M, Tuğrul S, Kekovalı M, Özden S, Kutlu T, Eroğlu M. Video Laparoscopic Approach in Cystic Ovarian Tumors. Endoscopic Laparoscopic Minimal Invasive Surgery, 3(3): 162-167, 1996.
61. Çetin A, Kara M, Kutlu T, Cantekin D. Asymptomatic Bacteriuria in Pregnancy and Its Relation to Maternal Anemia. Zeynep Kamil Medical Bulletin Gynecology-Obstetrics-Pediatrics Clinics, 28(4): 260-263, 1996.
62. Fıçıcıoğlu C, Kalay B, Cantekin D, Ünlü R, Solmaz E, Kutlu T. Investigation of Possible Risk Factors in Cases of Premature Rupture of Membranes. PTT Hospital Medical Journal, 17(3): 289-298, 1995.
63. Çetin A, Kara M, Kutlu T, Cantekin D. Induction of Labor with Intra-cervical Prostaglandin E2 Gel Application. PTT Hospital Medical Journal, 16(3): 289-294, 1994.
64. Kalay B, Fıçıcıoğlu C, Gürbüz A, Kumru A, Kutlu T. Fetal Breathing Movements and NST: Weak Indicators in Detecting Chorioamnionitis and Perinatal Infection Risk in Preterm Premature Rupture of Membranes. PTT Hospital Medical Journal, 16(2): 141-148, 1994.
65. Gürbüz A, Fıçıcıoğlu C, Kutlu T, Kalay B. Current Approach to Premalignant Lesions of the Cervix. PTT Hospital Medical Journal, 16(2): 121-127, 1994.
66. Gürbüz A, Fıçıcıoğlu C, Kalay B, Kutlu T. The Autoimmune Dimension of Recurrent Pregnancy Losses. PTT Hospital Medical Journal, 16(3): 279-287, 1994.
67. Fıçıcıoğlu C, Yıldırım A, Ünlü R, Cantekin D, Kutlu T. The Role of HCG in Early Pregnancy Nausea and Vomiting. PTT Hospital Medical Journal, 15(3): 343-357, 1993.
68. Akın S, Fıçıcıoğlu C, Ünlü R, Cantekin D, Kutlu T. Endovaginal Sonographic Assessment of Endometrial Thickness in Patients with Perimenopausal Abnormal Uterine Bleeding. PTT Hospital Medical Journal, 15(3): 331-338, 1993.
69. Fıçıcıoğlu C, Ertekin K, Ünlü R, Kutlu T. HAIR-AN Syndrome. PTT Hospital Medical Journal, 15(1): 101-109, 1993.
Articole evidențiate despre cancer